https://pmc.ncbi.nlm.nih.gov/articles/PMC39110/
Radioimmunotherapy with a 64Cu-labeled monoclonal antibody: a comparison with 67Cu - PMC
67Cu (t1/2 = 62 h) has demonstrated potential as a radionuclide for radioimmunotherapy, but limited availability severely restricts its widespread use. 64Cu...
with amonoclonal antibodylabeledcomparisonpmc
https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2022.889640/full
Frontiers | Theragnostic 64Cu/67Cu Radioisotopes Production With RFT-30 Cyclotron
64Cu and 67Cu are theragnostic pair radionuclides with promising application in the nuclear medicine. 64Cu is PET nuclide for the non-invasive diagnosis and ...
frontiersradioisotopesproductionrftcyclotron